Heterozygous NLRC4 gain-of-function mutations (OMIM #606831) lead to constitutive activation of the NLRC4 inflammasome resulting in enterocolitis and macrophage activation associated with a clinical picture of HLH. Here, NLRC4 is linked to hemophagocytic syndrome.